A study in Nature Medicine reveals that diabetes accelerates the onset of multiple long-term conditions by 15-20 years, significantly reducing life expectancy in English adults.
Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone
Plus, news about Adaptimmune, Roche, LIfT BioSciences, VerImmune, and Revance Therapeutics: Capricor Therapeutics to file Duchenne cardiomyopathy treatment with the FDA: The San Diego-based biotech